Fermann GJ, Cash BD, Coelho-Prabhu N, Maegele M, Bingisser R, Sehgal V, Cohen AT, Golden AH, Russo J, Price M, Mangel A, Koch B, Christoph MJ, Milling, Jr. TJ. Definition of factor Xa inhibitor–related, life-threatening gastrointestinal bleeding and guidance on when to use reversal therapy: a Delphi panel. J Am Coll Emerg Physicians Open. 2023 Oct 2;4(5):e13043. doi: 10.1002/emp2.13043
Hollis KA, Calingaert B, Price M, Andrews E, Moy L, Kooijmans M, Cristiano L, Bozic C. Tysabri TOUCH prescriber program risk management program (RiskMAP) surveys. Poster presented at the 26th ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 25, 2010. Brighton, United Kingdom.
Macdougall JE, Erder MH, Nelson LM, Price MA, Williams VS, Johnston JM. Correlational structure of IBS-C PRO symptom measures determined by exploratory factor analysis an relationship to global PRO assessments: results from a phase 2 trial of linaclotide in IBS-C. Poster presented at the 2009 NGM Scientific Meeting; 2009.
Parijs BAV, Price M, Leon F, Fehnel S. Relevance of the gastrointestinal symptom rating scale (GSRS) in patients with celiac disease. Poster presented at the American College of Gastroenterology 2008 Annual Scientific Meeting and Postgraduate Course; October 2008. Orlando, FL. [abstract] Am J Gastroenterol. 2008 Sep 1; 103(Suppl. S):S395.